Jeffrey Winkler

USPTO Granted Patents = 15 (Patent Applications = 5)

CIPO Patents = 1 (Patent Applications = 3)

EPO Patents = 4 (Patent Applications = 9)

Average Co-Inventor Count = 2.5

ph-index = 2

Forward Citations = 8(Granted Patents)

Company Filing History:

15 out of 2,597

University of Pennsylvania

where one patent can have more than one assignee

Years Active: 2013-2025

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12343339 - Bisaminoquinolines and bisaminoacridines compounds and methods of their use (2025-07-01),

2. 12077527 - Compositions and methods for inhibiting ACSS2 (2024-09-03),

3. 11639335 - Asymmetric bisaminoquinolines and bisaminoquinolines with varied linkers as autophagy inhibitors for cancer and other therapy (2023-05-02),

4. 11591298 - Bisaminoquinoline compounds, pharmaceutical compositions prepared therefrom and their use (2023-02-28),

5. 11369618 - Compounds, compositions and methods for prevention and/or treatment of cancer (2022-06-28),

6. 11001558 - Asymmetric bisaminoquinolines and bisaminoquinolines with varied linkers as autophagy inhibitors for cancer and other therapy (2021-05-11),

7. 10774047 - Dimeric quinacrine derivatives as autophagy inhibitors for cancer therapy (2020-09-15),

8. 10221140 - Asymmetric bisaminoquinolines and bisaminoquinolines with varied linkers as autophagy inhibitors for cancer and other therapy (2019-03-05),

9. 10071953 - Bifunctional AKR1C3 inhibitors/androgen receptor modulators and methods of use thereof (2018-09-11),

10. 10047052 - Bisaminoquinoline compounds, pharmaceutical compositions prepared therefrom and their use (2018-08-14),

11. 9540336 - Therapeutic agents (2017-01-10),

12. 9271961 - Bifunctional AKR1C3 inhibitors/androgen receptor modulators and methods of use thereof (2016-03-01),

13. 8759367 - Compounds and methods for the prevention and treatment of cancer (2014-06-24),

14. 8669243 - Steroid-derived cyclopamine analogs and methods for using the same in the prevention or treatment of cancer (2014-03-11),

15. 8575141 - Steroid-derived cyclopamine analogs and methods for using the same in the prevention or treatment of cancer (2013-11-05),

Title: **Jeffrey Winkler: Innovator in Neurological and Cancer Research**

Introduction

Jeffrey Winkler, located in Wynnewood, PA, is a notable inventor with a remarkable portfolio of 14 patents. His innovative work primarily focuses on compositions and methods that play a significant role in treating neurological diseases and cancers.

Latest Patents

Among his latest contributions to the field are two groundbreaking patents. The first patent, titled "Compositions and methods for inhibiting ACSS2," aims to provide methods for modulating histone acetylation, which is crucial for treating or preventing various neurological disorders. The second patent, "Asymmetric bisaminoquinolines and bisaminoquinolines with varied linkers as autophagy inhibitors for cancer and other therapy," encompasses novel compounds that demonstrate effective anticancer activity. These compounds are designed for the treatment of a variety of autophagy-related disorders.

Career Highlights

Throughout his career, Jeffrey Winkler has been associated with prominent institutions, including the University of Pennsylvania and The Wistar Institute. His academic and research contributions have been pivotal in advancing understanding in his fields of expertise.

Collaborations

In his innovative journey, Winkler has collaborated with notable peers such as Ravi Kumar Amaravadi and Nadia Dahmane. These collaborations have enhanced his research efforts and led to significant advancements in his patented inventions.

Conclusion

Jeffrey Winkler continues to be a driving force in the realms of neurological disease treatment and cancer research. His patents not only showcase his inventive spirit but also have the potential to make a lasting impact on medical science and patient care.

This text is generated by artificial intelligence and may not be accurate.